Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: A systematic review and meta-analysis

Ying Yang1, Dong Wu2, Hui Wang1

  • 1Department of Ultrasound, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.

Clinical Cardiology
|September 30, 2022
PubMed

Insights

Impaired left ventricular global longitudinal strain (LVGLS) in hypertrophic cardiomyopathy (HCM) patients indicates a higher risk of major adverse cardiovascular events (MACE). This finding highlights LVGLS as a crucial prognostic marker in HCM.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Clinical Research

Background:

  • Left ventricular global longitudinal strain (LVGLS) impairment is linked to adverse outcomes in hypertrophic cardiomyopathy (HCM).
  • Understanding the prognostic value of LVGLS in HCM is critical for patient management.

Approach:

  • A systematic meta-analysis was conducted using data from PubMed, Embase, Scopus, and Cochrane Library.
  • Evaluated the association between LVGLS and major adverse cardiovascular events (MACE) in 2441 HCM patients across 13 studies.
  • Calculated mean differences and pooled hazard ratios, addressing publication bias with trim-and-fill analysis.

Key Points:

  • Lower absolute LVGLS values were observed in HCM patients experiencing MACE (MD = 2.74, p < .001).
  • Impaired LVGLS demonstrated a significant association with MACE in both unadjusted (HR = 1.14, p < .05) and adjusted models (HR = 1.12, p < .05).
  • Sensitivity analyses confirmed the stability of results, despite identified publication bias.

Conclusions:

  • Impaired LVGLS is a significant predictor of poor prognosis in patients with hypertrophic cardiomyopathy.
  • Echocardiography-derived LVGLS serves as a valuable tool for risk stratification in HCM.
  • These findings support the integration of LVGLS assessment into routine clinical practice for HCM patients.
Abstract

Related Concept Videos